STOCK TITAN

Concorde International Group Ltd (CIGL) Financials

CIGL
FY2025 annual
Revenue $12.5M +18.9% YoY
Net Income -$15.2M YoY not available
Free Cash Flow -$3.7M -129.1% YoY
Operating Cash Flow -$3.5M -523.3% YoY
Market Cap $98.1M as of Sep 22, 2026
Price / Sales 7.9x on $12.5M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 23.3x on $4.2M equity, Q1 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended May 12, 2026 Reported Currency USD FYE May

Newest figures come from the 10-K for FY2025, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CIGL SEC filings page.

Concorde International Group Ltd (CIGL) reported $12.5M in revenue for fiscal year 2025, up 18.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CIGL FY2025

Revenue expansion is being overwhelmed by a sharp earnings and cash-conversion break, leaving financing to bridge operating needs.

The key break is between revenue scale and cash economics: revenue reached $12.5M in FY2025, but operating cash flow was -$3.5M. FY2023 had positive operating cash flow and net income, so greater scale did not translate into internally generated cash; free cash flow nearly matched operating cash flow despite limited capital expenditures, indicating operating losses—not reinvestment—drove most cash use.

Short-term liquidity tightened: the current ratio fell from 1.5x in FY2023 to 1.2x in FY2025. Accounts receivable reached $5.0M, making collection timing more important to the near-term asset cushion than the ratio alone suggests.

Debt remains modest at 0.1x equity, but FY2025 financing cash inflow of $4.2M arrived alongside negative operating cash flow. The reported liquidity measure was 5.6 months of latest annual operating outflow, reinforcing that cash availability and cash generation are different questions here.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 31 / 100
Financial Health Score 31/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Concorde International Group Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Concorde International Group Ltd, and counted as zero in the overall score.

Growth
60

Concorde International Group Ltd's revenue surged 18.9% year-over-year to $12.5M, reflecting rapid business expansion. This strong growth earns a score of 60/100.

Leverage
84

Concorde International Group Ltd carries a low D/E ratio of 0.05, meaning only $0.05 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
33

Concorde International Group Ltd's current ratio of 1.28 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
9

Concorde International Group Ltd's operations used $3.5M of cash, and capex of $187K added to the outflow, for a free cash flow shortfall of $3.7M. This results in a cash flow score of 9/100.

Returns
0

Not available for Concorde International Group Ltd, and counted as zero in the overall score.

Piotroski F-Score Partial
3/6

Concorde International Group Ltd passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Concorde International Group Ltd reported a net loss of $15.2M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt
$2.4M
QoQ+136.1%

Concorde International Group Ltd held $2.4M in cash against $230K in long-term debt as of Q1 2026, with $6.8M of liabilities due within a year.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Shares Outstanding

Not reported for Q1 2026.

Margins & Returns

None of these metrics is reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

CIGL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL quarterly income statement
MetricQ1'266-KQ3'256-KQ3'2410-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CIGL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL quarterly balance sheet
MetricQ1'266-KQ3'256-KQ3'2410-K
Total Assets$14.4M$10.3M+20.1%$8.6M
Current Assets$9.2M$5.4M+1.7%$5.3M
Cash & Equivalents$2.4M$1.0M+4.5%$957K
Accounts Receivable$6.3M$3.8M+9.7%$3.5M
Goodwill$9K$9K-96.9%$297K
Total Liabilities$10.2M$8.0M+37.0%$5.8M
Current Liabilities$6.8M$4.6M+30.3%$3.5M
Non-Current Liabilities$3.3M$3.4M+47.1%$2.3M
Long-Term Debt$230K$171K+89.5%$90K
Total Equity$4.2M$2.3M-16.4%$2.7M
Retained Earnings-$86.0M-$83.3M-46997.9%$178K

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.

CIGL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL quarterly cash flow statement
MetricQ1'266-KQ3'256-KQ3'2410-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

CIGL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIGL quarterly financial ratios
MetricQ1'266-KQ3'256-KQ3'2410-K
Current Ratio1.341.17-0.3x1.50
Debt-to-Equity0.050.080.0x0.03

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Concorde International Group Ltd CIGL FY2025 $12.5M -$15.2M N/A $98.1M 31/100
BIO-key International, Inc. BKYI FY2025 $5.9M $7.2M N/A $3.6M 24/100
Iveda Solutions, Inc. IVDA FY2025 $5.3M -$3.2M -60.6% $4.0M 55/100
SU Group Holdings Limited SUGP FY2025 $24.7M -$2.4M -9.6% $799K 43/100
VerifyMe, Inc. VRME FY2025 $16.4M -$4.9M -29.9% $10.5M 38/100

Frequently Asked Questions

What is Concorde International Group Ltd's annual revenue?

Concorde International Group Ltd (CIGL) reported $12.5M in total revenue for fiscal year 2025. This represents a 18.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Concorde International Group Ltd's revenue growing?

Concorde International Group Ltd (CIGL) revenue grew by 18.9% year-over-year, from $10.5M to $12.5M in fiscal year 2025.

Is Concorde International Group Ltd profitable?

No, Concorde International Group Ltd (CIGL) reported a net income of -$15.2M in fiscal year 2025.

As of fiscal year 2025, Concorde International Group Ltd (CIGL) had $1.6M in cash and equivalents against $200K in long-term debt.

Concorde International Group Ltd (CIGL) has a return on equity of -410.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Concorde International Group Ltd (CIGL) recorded an outflow of $3.7M in free cash flow during fiscal year 2025. This represents a -129.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Concorde International Group Ltd (CIGL) recorded an outflow of $3.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Concorde International Group Ltd (CIGL) had $11.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Concorde International Group Ltd (CIGL) invested $187K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Concorde International Group Ltd (CIGL) had 7M shares outstanding as of fiscal year 2025.

Concorde International Group Ltd (CIGL) had a current ratio of 1.28 as of fiscal year 2025, which is considered adequate.

Concorde International Group Ltd (CIGL) had a debt-to-equity ratio of 0.05 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Concorde International Group Ltd (CIGL) had a return on assets of -134.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Concorde International Group Ltd (CIGL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $98.1M as of Sep 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Concorde International Group Ltd (CIGL) trades at 7.9x sales, its market capitalization divided by revenue of $12.5M revenue, FY2025. The market capitalization is $98.1M as of Sep 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Concorde International Group Ltd (CIGL) held $1.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.5M over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Concorde International Group Ltd (CIGL) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Concorde International Group Ltd (CIGL) reported a net loss of $15.2M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Concorde International Group Ltd (CIGL) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top